1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Depomed

Anonymous board for Depomed


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    50
    Views:
    11,861
  2. anonymous
    Replies:
    14
    Views:
    4,356
  3. anonymous
    Replies:
    2
    Views:
    2,019
  4. anonymous
    Replies:
    8
    Views:
    3,460
  5. anonymous
    Replies:
    4
    Views:
    3,506
  6. anonymous
    Replies:
    0
    Views:
    1,225
  7. anonymous
    Replies:
    16
    Views:
    5,875
  8. anonymous
    Replies:
    19
    Views:
    7,822
  9. anonymous
    Replies:
    1
    Views:
    1,169
  10. anonymous
    Replies:
    32
    Views:
    5,497
  11. anonymous
    Replies:
    1
    Views:
    1,313
  12. anonymous
    Replies:
    6
    Views:
    2,554
  13. anonymous
    Replies:
    1
    Views:
    1,143
  14. anonymous
    Replies:
    16
    Views:
    6,464
  15. anonymous
    Replies:
    22
    Views:
    6,394
  16. Nope
    Replies:
    2
    Views:
    1,723
  17. anonymous
    Replies:
    3
    Views:
    1,462
  18. Sookim
    Replies:
    4
    Views:
    1,333
  19. anonymous
    Replies:
    0
    Views:
    1,453
  20. anonymous
    Replies:
    37
    Views:
    11,824

Thread Display Options

Loading...